Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.874
+0.014 (1.66%)
Nov 21, 2024, 4:00 PM EST - Market closed
Kronos Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -85.59 | -112.67 | -133.2 | -151.08 | -88.44 | -16.12 | Upgrade
|
| Depreciation & Amortization | 1.79 | 2.14 | 2.27 | 1.98 | 0.84 | 0.36 | Upgrade
|
| Other Amortization | - | - | - | - | 3.89 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.25 | 0.25 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 11.76 | 2.92 | - | - | 3.57 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.67 | -5.34 | -0.53 | 4 | 0.33 | -0 | Upgrade
|
| Stock-Based Compensation | 12.73 | 24.98 | 31.15 | 26.21 | 3.75 | 0.11 | Upgrade
|
| Other Operating Activities | 3.03 | 3.27 | 3.22 | 2.59 | 31.7 | 0.29 | Upgrade
|
| Change in Accounts Payable | -2.8 | -4.15 | 4.03 | -3.2 | 2.81 | 0.72 | Upgrade
|
| Change in Unearned Revenue | -9.87 | 13.71 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -5.25 | -3.69 | 2.15 | 1.58 | 3.65 | -0.44 | Upgrade
|
| Operating Cash Flow | -77.62 | -78.58 | -90.93 | -117.92 | -37.91 | -15.08 | Upgrade
|
| Capital Expenditures | -0.03 | -0.68 | -0.58 | -4.26 | -9.57 | -2.95 | Upgrade
|
| Investment in Securities | 94.67 | 67.05 | -31.65 | 67.98 | -150.67 | -64.63 | Upgrade
|
| Investing Cash Flow | 94.64 | 66.37 | -32.22 | 63.72 | -160.24 | -67.58 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 151.28 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.01 | -0.03 | -0.03 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.01 | 151.24 | -0.03 | Upgrade
|
| Issuance of Common Stock | 0.35 | 0.57 | 0.85 | 4.47 | 264.37 | 0.12 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -0.08 | Upgrade
|
| Financing Cash Flow | 0.35 | 0.57 | 0.85 | 4.46 | 415.61 | 105.01 | Upgrade
|
| Net Cash Flow | 17.37 | -11.65 | -122.3 | -49.74 | 217.47 | 22.34 | Upgrade
|
| Free Cash Flow | -77.66 | -79.26 | -91.5 | -122.18 | -47.48 | -18.03 | Upgrade
|
| Free Cash Flow Margin | -787.18% | -1260.51% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.30 | -1.37 | -1.63 | -2.23 | -2.92 | -3.42 | Upgrade
|
| Levered Free Cash Flow | -51.37 | -43.83 | -43.3 | -72.4 | -35.88 | -12.45 | Upgrade
|
| Unlevered Free Cash Flow | -50.33 | -43.83 | -43.3 | -72.4 | -37.34 | -12.45 | Upgrade
|
| Change in Net Working Capital | 8.5 | -2.99 | -9.56 | 1.7 | -3.91 | -0.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.